421 results
DEFA14A
BIIB
Biogen Inc
7 Jun 22
Additional proxy soliciting materials
4:37pm
acknowledges that some stockholders expressed concern with this payment and notes that it was one-time in nature based on the specific facts … discussed with our stockholders that the 2020 severance payment was one-time in nature based on the specific facts and circumstances of the transitioning
8-K
EX-10.1
BIIB
Biogen Inc
26 Aug 13
Departure of Directors or Certain Officers
12:00am
Officer position at entities of the Company's size and nature. The Executive shall be assigned no duties or authorities that are materially inconsistent … to reasonable travel requirements consistent with the nature of the Executive's duties from time to time on behalf of the Company.
2.Term of Employment
8-K
EX-99.1
BIIB
Biogen Inc
6 Sep 07
Biogen Idec Announces Strategic Updates at Investor Meetings
12:00am
the company cannot predict with certainty the nature or the amount of non-operating or unusual charges for 2007, we have made no assumption regarding future … items.
Because the company cannot predict with certainty the nature or the amount of non-operating or unusual charges through 2010, it has made
8-K
EX-99.1
BIIB
Biogen Inc
26 Oct 16
Biogen Reports Record Third Quarter 2016 Revenues of $3.0 Billion
12:00am
study for aducanumab in early Alzheimer’s disease were published in Nature. The full manuscript titled “The Antibody Aducanumab Reduces Aâ Plaques … in Alzheimer’s Disease” can be found in the September 1, 2016 issue of Nature http://www.nature.com/nature/journal/v537/n7618/full/nature19323.html
8-K
EX-10.1
dz8tjvzluxlpcv6y
1 Jul 10
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
lqj63586b kck6
7 Jan 08
Biogen Idec Provides Business Update at Investor Meeting
12:00am
8-K
EX-10.1
66ue3zaennk
3 May 22
Biogen Reports First Quarter 2022 Results
7:11am
8-K
EX-3.2
hkuad0neid4hevozme
13 Jun 12
Amendments to Articles of Incorporation or Bylaws
12:00am
CORRESP
jjlghqb9y24ws5z
7 Apr 21
Correspondence with SEC
12:00am
CORRESP
gexy5zrnpw27sn1ve8sh
24 Apr 12
Correspondence with SEC
12:00am
8-K
EX-10.1
p4u3jmk 5pthzx8d1mv
10 Nov 22
Biogen Names Christopher Viehbacher President and Chief Executive Officer
7:26am